With regard to prognosis, reduced TTC17 expression was also correlated with shorter RFS in ovarian cancer and testicular germ cell tumors, together with dismal OS in bladder carcinoma, pancreatic ductal adenocarcinoma, rectum adenocarcinoma, and stomach adenocarcinoma (Fig. 2b, c, Additional file 2: Fig. S2a-d). Here, TTC17 is linked to pancreatic ductal adenocarcinoma.